At the same time, our results indicate that a reduction of Shh-pathway activation by blockage with Cyclopamine might be associated with reduced NPC-survival, reduced general differentiation and increased astroglial differentiation. This evidence concerns the gene SHH and nasopharyngeal carcinoma.